These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25087226)

  • 1. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
    Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
    J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
    Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
    J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
    Lork M; Staal J; Beyaert R
    Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
    Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
    Front Immunol; 2018; 9():2078. PubMed ID: 30283440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CBM signalosome: potential therapeutic target for aggressive lymphoma?
    Yang C; David L; Qiao Q; Damko E; Wu H
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):175-83. PubMed ID: 24411492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
    Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline CBM-opathies: From immunodeficiency to atopy.
    Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
    J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
    Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
    J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.
    Thome M; Charton JE; Pelzer C; Hailfinger S
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a003004. PubMed ID: 20685844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
    Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
    J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
    Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
    Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
    McCully RR; Pomerantz JL
    Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
    Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
    J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome.
    Paul S; Traver MK; Kashyap AK; Washington MA; Latoche JR; Schaefer BC
    Sci Signal; 2014 May; 7(325):ra45. PubMed ID: 24825920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
    Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
    Front Immunol; 2018; 9():2695. PubMed ID: 30515170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.
    Chan W; Schaffer TB; Pomerantz JL
    Mol Cell Biol; 2013 Jan; 33(2):429-43. PubMed ID: 23149938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
    Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
    J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.